The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of dementia characterized by the deposition of extracellular amyloid-β (Aβ)-containing plaques, the formation of intraneuronal neurofibrillary tangles as well as neuroinflammatory changes. As the key player in the brain innate immune system, microglia...
Main Authors: | Li Zhong, Xiao-Fen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2019.00328/full |
Similar Items
-
TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics
by: Feng Xue, et al.
Published: (2021-02-01) -
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
by: Marc Suárez‐Calvet, et al.
Published: (2018-12-01) -
Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
by: Nicholas F. Fitz, et al.
Published: (2020-07-01) -
TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
by: Honghua Zheng, et al.
Published: (2018-11-01) -
TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
by: Yingyue Zhou, et al.
Published: (2018-07-01)